ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 605,97
0,47%
Dow Jones
38 834,86
0,15%
DAX
18 170,59
0,57%
Brent Oil
84,575
-0,14%
Bitcoin
65 720,09
1,16%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Karyopharm Therapeutics Inc (KPTI)

  7. Karyopharm Therapeutics Inc (KPTI) Actualités

KPTI Karyopharm Therapeutics Inc

0,93
0,00 (0,00%)
Avant marché
Dernière mise à jour : 10:00:00
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Karyopharm Therapeutics Inc KPTI NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,00 0,00% 0,93 10:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
0,93
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
10/6/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
06/6/202422:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202422:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/6/202422:05PRNUSKaryopharm Therapeutics Reports Inducement Grants Under..
01/6/202419:45PRNUSKaryopharm Presents Updated Exploratory Subgroup Analyses..
31/5/202414:00EDGAR2Form 8-K - Current report
30/5/202423:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/5/202423:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/5/202422:44EDGAR2Form S-3 - Registration statement under Securities Act of..
30/5/202422:06EDGAR2Form S-8 - Securities to be offered to employees in employee..
29/5/202422:05PRNUSKaryopharm to Participate at the Jefferies Global Healthcare..
23/5/202422:30EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14/5/202422:06EDGAR2Form 8-K - Current report
08/5/202422:13EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/5/202422:05PRNUSKaryopharm to Participate at the 2024 RBC Capital Markets..
08/5/202413:52EDGAR2Form 8-K - Current report
08/5/202413:47EDGAR2Form 8-K - Current report
08/5/202413:30PRNUSKaryopharm Reports First Quarter 2024 Financial Results and..
07/5/202422:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/5/202422:30PRNUSKaryopharm to Report First Quarter 2024 Financial Results on..
01/5/202422:05PRNUSKaryopharm Therapeutics Reports Inducement Grants Under..
24/4/202422:01PRNUSKaryopharm Announces Presentations in Endometrial Cancer and..
01/4/202422:05PRNUSKaryopharm Therapeutics Reports Inducement Grants Under..
06/3/202422:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202422:05PRNUSKaryopharm to Participate at Barclays 26th Annual Global..
05/3/202401:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202401:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202401:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202401:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202401:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202401:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202422:05PRNUSKaryopharm Therapeutics Reports Inducement Grants Under..
29/2/202423:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202423:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202423:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202423:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202423:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202423:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202413:43EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
29/2/202413:35EDGAR2Form 8-K - Current report
29/2/202413:30PRNUSKaryopharm Reports Fourth Quarter and Full Year 2023..
22/2/202413:00PRNUSKaryopharm to Report Fourth Quarter and Full Year 2023..
20/2/202422:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202414:00EDGAR2Form 8-K - Current report
14/2/202416:33EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12/2/202412:06EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/2/202422:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202422:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202422:05PRNUSKaryopharm Therapeutics Reports Inducement Grants Under..
26/1/202401:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Dernières Valeurs Consultées

NASDAQ
KPTI
Karyopharm Therapeutics
LSE
QH86
Morg.st.b.v 27
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés